The guidelines draw on the latest scientific and programmatic evidence and set out over 50 recommendations across clinical practice, health service delivery, and legal and policy interventions to expand access to quality abortion care.
MSI Reproductive Choices’ Global Medical Director, Dr Dhammika Perera, said:
“Abortion is an essential and common healthcare service needed by women everywhere, yet access to safe and legal abortion care remains out of reach for many. As a result of unsafe abortion, seven million women a year suffer complications and over 22,000 women die.
“As one of the world’s leading providers of abortion care, we were proud to contribute our clinical and programmatic evidence to the WHO’s new guideline on abortion care, which if implemented would transform access, save thousands of lives and give millions of women and girls control over their bodies and their futures.
We are delighted to see the world’s leading health body supporting the human rights of women and girls through access to abortion care that respects their needs and decisions. We look forward to working closely with the WHO and national governments to turn these recommendations into reality.”
– Ends –
Notes to Editors
For interviews and further information please contact:
Email: [email protected]
Tel: (+44) 07769 166 516
About MSI Reproductive Choices
MSI Reproductive Choices is one of the world’s leading providers of sexual and reproductive healthcare. We believe that everyone should have the right to choose. From contraception to safe abortion and life-saving post-abortion care, we are committed to delivering compassionate, affordable, high-quality services for all. Our organisation has over 9,000 team members working across 37 countries, supporting over 67,000 people to access reproductive choice every day.
